What Are the Indications for Drug Eluting Technology in Peripheral Artery Disease Management?
European Journal of Vascular and Endovascular Surgery · 2026-06 · 71 (6) · 918-920
DOI: 10.1016/j.ejvs.2026.02.047 ↗Kurz gefasst
Editorial in der Zeitschrift European Journal of Vascular and Endovascular Surgery, 2026-06. Verfasst von Christian-Alexander Behrendt und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular and Endovascular Surgery, Asklepios Clinic Wandsbek, Asklepios Medical School Hamburg, Hamburg, Germany. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Vascular and Endovascular Surgery, Asklepios Clinic Wandsbek, Asklepios Medical School Hamburg, Hamburg, Germany.
- Division of Vascular Surgery and Endovascular Therapy, University of Vermont Medical Center, Burlington, VT, USA. Electronic address: daniel.bertges@uvmhealth.org.
Zitieren
APA
Behrendt, C. A., & Bertges, D. J. (2026). What Are the Indications for Drug Eluting Technology in Peripheral Artery Disease Management?. European Journal of Vascular and Endovascular Surgery, 71(6), 918-920. https://doi.org/10.1016/j.ejvs.2026.02.047
Vancouver
Behrendt CA, Bertges DJ. What Are the Indications for Drug Eluting Technology in Peripheral Artery Disease Management?. European Journal of Vascular and Endovascular Surgery. 2026;71(6):918-920. doi:10.1016/j.ejvs.2026.02.047
BibTeX
@article{Behrendt2026,
author = {Behrendt, Christian-Alexander and Bertges, Daniel J},
title = {What Are the Indications for Drug Eluting Technology in Peripheral Artery Disease Management?},
journal = {European Journal of Vascular and Endovascular Surgery},
year = {2026},
volume = {71},
number = {6},
pages = {918--920},
doi = {10.1016/j.ejvs.2026.02.047}
}
EUVIMED